{"id":7606,"date":"2017-07-30T05:00:16","date_gmt":"2017-07-30T09:00:16","guid":{"rendered":"https:\/\/medicarereport.org\/?p=7606"},"modified":"2017-07-28T07:38:18","modified_gmt":"2017-07-28T11:38:18","slug":"fda-head-seeks-unlikely-allies-in-opioid-fight-insurers-and-pbms","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=7606","title":{"rendered":"FDA head seeks unlikely allies in opioid fight: Insurers and PBMs"},"content":{"rendered":"<p>(By Brian Zimmerman for Becker&#8217;s Hospital Review)<\/p>\n<p>Scott Gottlieb, MD, commissioner of the Food and Drug Administration, plans to meet with insurance administrators and pharmacy benefit managers in September to see if the organizations can help reduce the amount of opioids dispensed in the U.S., according to\u00a0<a href=\"https:\/\/www.bloomberg.com\/news\/articles\/2017-07-24\/trump-s-fda-commissioner-on-drug-prices-regulations-science\"><em>Bloomberg<\/em><\/a>. Continue reading article here&#8230;<\/p>\n<pre style=\"border: 1px solid #eaeaea; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; font-stretch: inherit; line-height: 1.4; font-family: 'Courier 10 Pitch', Courier, monospace; font-size: 14px; font-style: normal; font-weight: normal; margin: 0px 0px 20px; outline: 0px; padding: 20px; vertical-align: baseline; background-color: #ffffff; overflow: auto; white-space: pre-wrap; color: #444444; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;\"><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Brian Zimmerman for Becker&#8217;s Hospital Review) Scott Gottlieb, MD, commissioner of the Food and Drug Administration, plans to meet<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-7606","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/7606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7606"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/7606\/revisions"}],"predecessor-version":[{"id":7607,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/7606\/revisions\/7607"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}